Frailty and safety: the example of diabetes. - Wikidata - awgldk - TriplyDB

Frailty and safety: the example of diabetes.

Frailty and safety: the example of diabetes.

http://www.wikidata.org/entity/Q38085225

about

Optimal therapy of type 2 diabetes: a controversial challenge Incidence of Low Body Mass Index in the Elderly in Forensic Cases-A Possible Marker for Frailty Syndrome?Physiological Aging: Links Among Adipose Tissue Dysfunction, Diabetes, and Frailty.Sarcopenia: a chronic complication of type 2 diabetes mellitus.

P2860

Q33577712-DCBC20AC-F0A2-486F-8E81-DF7035CF1748 Q38819494-C4AC42C1-EFB4-473A-A752-0489EB906CB6 Q39032248-2C3A48F7-881D-41A9-9E51-8CCCDD5518FE Q55279966-1C265771-C10C-42A0-838D-6FDDC32A8042

P2860

Frailty and safety: the example of diabetes.

http://www.wikidata.org/entity/Q38085225

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Frailty and safety: the example of diabetes.

@en

type

label

Frailty and safety: the example of diabetes.

@en

prefLabel

Frailty and safety: the example of diabetes.

@en

P1433

Q38085225-90598758-26D2-43C5-9DA4-BE85DCEFA7B9

P1476

Q38085225-84E30EB3-CE79-44FB-98CE-509DE11BBE18

P2093

Q38085225-31F99A47-DFC9-452F-8CF6-143AF624E1BE

Q38085225-348602A1-3745-45A9-A03B-3D2DC7288835

Q38085225-494B177F-76D7-4038-8E0A-F17C57EB978F

Q38085225-D3E5D1AC-D238-41C3-91AD-6CE9257AAAF4

P2860

Q38085225-04D905C6-91D6-49F5-99CC-27C57CB2AEBF

Q38085225-07CE8D17-7E02-455A-A321-5777432131AB

Q38085225-080B9D2C-5F78-4B42-A18D-37CAE40B22F1

Q38085225-1472F46C-0242-42B5-9F06-F9A572406286

Q38085225-158631B6-6A4D-4912-A70B-81815E514DE4

Q38085225-1C50CFA4-EB59-476B-BA20-4DA38DFAF8BE

Q38085225-222D3881-2BB0-4110-B4AD-90399CA0467D

Q38085225-2401B37D-85F5-4A10-BAC5-FD6B849C7C0D

Q38085225-2557BA35-22C1-41E8-AC08-482F39339226

Q38085225-287474E7-3659-4443-BCE1-697C0C74F258

P2888

Q38085225-D86D15FA-0364-4621-BEE5-96968EC93B4A

P304

Q38085225-904ED249-9AA7-4777-97BA-1CE1DF08BF0D

P31

Q38085225-383EDFD8-1485-4001-98E9-AE57A14110C8

P356

Q38085225-949CD384-F678-4EC8-89BA-68402D8F9B6F

P478

Q38085225-786A5273-4CF7-4116-B07E-281DF5E9B2B3

P50

Q38085225-0CEF142F-BAF9-46F5-BE90-6BB661D21856

Q38085225-6909DF49-75CB-48A7-9C1B-7464A6CEFAF6

P577

Q38085225-2578BBA3-A49D-49E9-9FA3-02D68C560F92

P6179

Q38085225-AFC9EB2C-0A64-4B37-B6A1-71FC4AA27F1A

P698

Q38085225-4CF62201-DDB2-49F3-BB18-C5F823DC087E

P356

P1433

P1476

Frailty and safety: the example of diabetes.

@en

P2093

Alessia Fumagalli

http://www.w3.org/2001/XMLSchema#string

Andrea Corsonello

http://www.w3.org/2001/XMLSchema#string

Angela M Abbatecola

http://www.w3.org/2001/XMLSchema#string

Felice Strollo

http://www.w3.org/2001/XMLSchema#string

P2860

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis

Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation

Inflamm-aging. An evolutionary perspective on immunosenescence

Income-related differences in the use of evidence-based therapies in older persons with diabetes mellitus in for-profit managed care

Frailty in older adults: evidence for a phenotype

Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08).

P2888

P304

63-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF03319104

http://www.w3.org/2001/XMLSchema#string

P478

35 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Fabiola Olivieri

Fabrizia Lattanzio

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029457659

http://www.w3.org/2001/XMLSchema#string

P698

23446787

http://www.w3.org/2001/XMLSchema#string